The Frequency of myocarditis in patients with COVID-19 and in-hospital mortality.
Myocarditis and COVID.19
Keywords:
COVID-19, Myocarditis, in-hospital mortalityAbstract
Objective: To determine the frequency of myocarditis in patients with COVID-19 and in-hospital mortality.
Study design: Observational cohort study.
Study setting and duration: Fifty five patients between 15-70 years of age, admitted in corona ward of Aziz Bhatti Shaheed Teaching Hospital, Nawaz Sharif Medical College, Gujrat from 15 to 30th march 2020.
Material and methods: Patients with positive PCR results for covid-19 were included in this study after informed consent; patients with prior history of any cardiovascular, pulmonary or other co-morbidity were excluded while patients having history of hypertension, diabetes or smoking were included in the study. All the patients remain admitted for 14 days. Patients were evaluated clinically, by ECG, troponins and echocardiographically for diagnosis of myocarditis. Patients were managed conservatively. Incidence of myocarditis and in-hospital mortality was noted. Successful treatment towards hospital discharge was relief of clinical symptoms, a-febrile, clear chest X-Ray and at least two consecutive negative PCR for covid-19. p value <0.05 was considered as significant. Data was analyzed with SPSS -23.
Results: Out of fifty five, 5(9%) patients were diabetics and 4 were hypertensive. Five (9%) developed mild pneumonia which recovered conservatively and three (5.4%) patients developed myocarditis. One (1.8%) patient expired having myocarditis. Duration of follow up was only during hospital stay. So our in-hospital mortality was 1.8%, p value was calculated as significant < 0.05.
Conclusion: Myocarditis is a known but less common complication of COVID-19. Cardiac injury is more in those with previously having cardiovascular or other co-morbidities. In healthy and immunocompetent population its incidence is quite low.
References
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401-402. doi:10.1002/jmv.25678
Hui DS, I Azhar E, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel
coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China. IntJ
Infect Dis.2020;91:264-266.
Paules CI, Marston HD, Fauci AS. Coronavirus infections: more than just the common cold. JAMA. Published online January 23, 2020. doi:10.1001/jama. 2020.0757
Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. Published February 7, 2020. doi:10.1001/jama.2020.158
Tao Guo, MD; Yongzhen Fan, MD; Ming Chen, MD et al Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) .JAMA Cardiol Published online March 27, 2020 AMA Cardiol. doi:10.1001/jamacardio.2020.1017
Edwards S, Small JD, Geratz JD, Alexander LK, Baric RS. An experimental model for myocarditis and congestive heart failure after rabbit coronavirus infection. J Infect Dis. 1992;165(1):134-40.doi:10.1093/infdis/165.1.134.
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement 1 with coronavirus 2019 (COVID-19) infection. JAMA Cardiol. 2020. doi:10.1001/ jamacardio.2020.1096 67.
Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020: ehaa190. doi:10.1093/eurheartj/ehaa190
Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36(1):227-232.
Friedrich MG, Sechtem U, Schulz-Menger J, et al; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53(17):1475-1487.
Fabre A, Sheppard MN. Sudden adult death syndrome and other non ischemic causes of sudden cardiac death. Heart. 2006 Mar;92(3):316-320. Epub 2005 May 27. .
Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID): first epidemiological results. Herz. 2000;25(3):279-285
Dec GW Jr, Waldman H, Southern J, Fallon JT, Hutter AM Jr, Palacios I.Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol.1992;20(1):85-89.
Peiris JS, Chu CM, Cheng VC, et al; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of corona virus associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767-1772. doi:10.1016/ S0140-6736(03)13412-5 27.
